Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 33 Ovarian Neoplasms 9 Breast Neoplasms 9 Pancreatic Neoplasms 8 Metastatic Castration-resistant Prostate Cancer 5 Carcinoma, Renal Cell 5 Urinary Bladder Neoplasms 4 Neoplasm Metastasis 4 Triple Negative Breast Neoplasms 3 Sarcoma 3 Lymphoma, Non-Hodgkin 3 Endometrial Neoplasms 3 Carcinoma, Transitional Cell 3 Wilms Tumor 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Prostatic Neoplasms, Castration-Resistant 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Medulloblastoma 2 Lung Neoplasms 2 Histiocytosis, Langerhans-Cell 2 Hereditary Sensory and Autonomic Neuropathies 2 Hepatoblastoma 2 Glioma 2 Ependymoma 2 Central Nervous System Neoplasms 2 Castration-Resistant Prostate Carcinoma 2 Xanthogranuloma, Juvenile 1

Interventions

aldesleukin 43 Sunitinib 42 Cyclophosphamide 30 Nivolumab 29 pembrolizumab 27 Everolimus 27 Interferon-alpha 25 Bevacizumab 23 Sorafenib 22 Interleukin-2 20 fludarabine phosphate 19 Radiotherapy 18 Ipilimumab 18 Filgrastim 18 Axitinib 18 Gene Expression Profiling 16 Peripheral Blood Stem Cell Transplantation 15 Gemcitabine 15 cabozantinib 14 Radiosurgery 13 fludarabine 11 Doxorubicin 11 Carboplatin 11 Blood Specimen Collection 11 temsirolimus 10 atezolizumab 9 Immunohistochemistry 9 Etoposide 9 Chemotherapy, Adjuvant 9 sargramostim 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Kidney Neoplasms × olaparib × Genitourinary × Clear all

NCT03786796 2026-03-30

ORCHID

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡